/ Pack :
1 X 10’s
/ Type :
Preliminary evidence suggests that the blood pressure-lowering effects of candesartan are associated with the prevention or improvement of end-organ damage in patients with hypertension. Candesartan improves insulin sensitivity in patients with hypertension and does not affect glucose homeostasis or the serum lipid profile in those with coexisting type 2 (non-insulin-dependent) diabetes mellitus. Candesartan is well tolerated in patients with hypertension. Pooled data indicate that the tolerability profile of the drug is not significantly different from that of placebo, with headache being the most commonly reported event. Candesartan is better tolerated than enalapril, primarily because of a reduced incidence of cough and was not associated with the hypokalaemia or hyperuricaemia seen with hydrochlorothiazide in a study in patients aged > or = 75 years - Drugs. 1998 Nov;56(5):847-69.
View more products with following salts